Electroacupuncture ameliorates neuroinflammation by inhibiting TRPV4 channel in ischemic stroke

作者：Xueqi Ren, Xinyi Gao, Ziqing Li, Yangyang Ding, Ao Xu, Lixia Du, Yufang Yang, Deheng Wang, Zhifei Wang, Shi Shu · 发表于：CNS Neuroscience & Therapeutics · 年份：2024 · DOI：10.1111/cns.14618 · 被引用次数：49 · 研究领域：Acupuncture Treatment Research Studies、Pain Mechanisms and Treatments、Neuroinflammation and Neurodegeneration Mechanisms

AIMS: We investigated the potential mechanisms underlying the therapeutic efficacy of electroacupuncture (EA) at the Shuigou (GV26) and Baihui (GV20) acupoints in the treatment of ischemic stroke. METHODS: We assessed the therapeutic effects of EA on MCAO mice through behavioral studies and TTC staining. Various techniques, such as RT-PCR, immunofluorescence, and Western blots, were employed to evaluate the activation and polarization of microglia/macrophages, and changes in the TRPV4 ion channel. We used the TRPV4 antagonist GSK2193874 (GSK219) to verify the involvement of TRPV4 in the therapeutic effects of EA. RESULTS: EA effectively improved neurological impairments and reduced cerebral infarction volume in MCAO mice. It suppressed activated microglia/macrophages and inhibited their polarization toward the M1 phenotype post-MCAO. EA also downregulated the expression of pro-inflammatory cytokines, including Tnf-α, Il-6, Il-1β, and Ccl-2 mRNA. Furthermore, EA reduced the elevated expression of TRPV4 following MCAO. Treatment with the TRPV4 antagonist GSK219 mirrored the effects of EA in MCAO mice. Notably, the combination of EA and GSK219 did not demonstrate an additive or synergistic effect. CONCLUSION: EA may inhibit neuroinflammation and exhibit a protective effect against ischemic brain injury by suppressing TRPV4 and the subsequent M1 polarization of microglia/macrophages.